Genoway S.A. Actions Port. EO -,60

Sector and Industry

Healthcare, Healthcare Services

Performance (1Y)

19.46%

Market Cap

-

P/E Ratio

35.33

Dividend Yield

0.00 %

Earnings per Share

0.08 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
UnitedHealth Group Inc.254.66 Bil.396.73 Bil.24.94
-19.75 %
0.00
-
Thermo Fisher Scientific Inc.185.62 Bil.39.50 Bil.32.67
+1.45 %
0.00
-
Danaher Corp.137.79 Bil.21.78 Bil.45.36
-11.47 %
0.00
-
McKesson Corporation90.13 Bil.348.09 Bil.22.55
+33.83 %
0.00
-
HCA Healthcare Inc.89.28 Bil.67.01 Bil.16.48
+12.93 %
0.00
-
Elevance Health Inc.65.88 Bil.176.51 Bil.13.91
-9.22 %
0.00
-
The Cigna Group61.74 Bil.243.65 Bil.12.41
+66.33 %
0.00
-
Cencora Inc.51.58 Bil.291.15 Bil.39.26
+1.16 %
0.00
-
IDEXX Laboratories Inc.45.92 Bil.3.81 Bil.51.74
+14.41 %
0.00
-
Zoetis Inc.45.52 Bil.8.39 Bil.20.89
+3.10 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE2.38 G0 Units
PRICE DETERMINATION TIME07/22/2026 / 05:31:56 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW2.482.37
PREV. DAY'S PRICE2.4 (07/21)
CHANGE DAY BEFORE
-0.02
-0.83 %
52 WEEK HIGH / LOW3.05 (09/26)2.03 (11/19)
More Price Information

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
0.170.200.080.000.10
DIVIDENDS PER SHARE
0.000.000.000.000.00
DIVIDEND YIELD IN %
0.00 %0.00 %0.00 %--
DIVIDEND GROWTH IN %
-----
PRICE - EARNINGS RATIO
26.4818.6835.33-24.80
PRICE - BOOK RATIO
2.732.001.33--
PRICE - SALES RATIO
2.071.551.56--
PRICE - CASH FLOW RATIO
-----
Further Key Figures

Master Data

WKN
A0MRJ4
ISIN
FR0004053510
SYMBOL
JEH
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
GENOWAY S.A. INH. EO-,60
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
-
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Healthcare Services
NUMBER OF SHARES
-
MARKET CAPITALISATION
-

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
10.09 %
8.60 %
-3.23 %
-4.00 %
-19.46 %
-34.96 %
-
-5.51 %
HIGH2.602.602.692.693.054.71-2.69
LOW2.152.122.122.122.032.03-2.12

Dividende

pro Aktie
GENOWAY S.A. INH. EO-,60 does not deliver dividend information

Company profile

genOway SA engages in the development of genetically modified mouse, rat, and cellular models for biopharmaceutical and research companies. Its technologies include CRISPR/Cas9, homologous recombination (HR), site-specific recombination (SSR), internal ribosome entry sites (IRES), and tetracycline (TET). The company was founded by Alexandre Fraichard and Gilles de Poncins on March 1, 1999, and is headquartered in Lyon, France.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.